Tri-Cell
Price range: $64.95 through $104.95
- Buy 5+ of each and save 5%
- Buy 10+ of each and save 8%
- Product is sold in powder form, needs reconstitution before use. Please read more on our FAQ page.
Tricell is an investigational once-weekly triple hormone receptor agonist. It activates three receptors—GIP, GLP-1, and glucagon—making it distinct from dual-agonist compounds.
SHARE:
SHARE:
- Products sold on our website are designed for in vitro testing and lab experimentation exclusively.
- All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
- The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
- The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
AVAILABILITY:
- Ships today if you order and pay by 12 PM CST
- Some product may take up to 72 hours to ship
- Backordered items will ship in 3-5 days
**Tricell** is an investigational once-weekly triple hormone receptor agonist. It is a single molecule designed to activate three key receptors in the body: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon . This triple-action mechanism distinguishes it from currently available dual-agonist medications.
### 🧬 Mechanism of Action
Tricell works by targeting three hormonal pathways simultaneously :
| Receptor Target | Primary Role |
|—————–|————–|
| **GLP-1** | Reduces appetite, slows gastric emptying, regulates insulin and glucagon |
| **GIP** | Enhances insulin secretion and modulates fat metabolism |
| **Glucagon** | Increases energy expenditure and promotes fat burning |
The addition of glucagon receptor agonism is particularly significant. While GLP-1 and GIP primarily work by curbing food intake, the glucagon arm appears to increase energy expenditure and liver fat burning—working on the “output” side of the energy equation . This may explain why tricell has produced greater weight loss in clinical trials compared to dual-agonist medications .
### ⚠️ Side Effects
The most commonly reported side effects in clinical trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation . These effects were dose-dependent and typically occurred during dose escalation .
A novel side effect unique to tricell is **dysesthesia**—unusual skin sensations such as tingling, burning, or hypersensitivity. This occurred in approximately 7% of participants and appeared to be reversible after stopping the medication .
### 🔬 Current Status
Tricell is not yet approved by the FDA and is currently available only to participants in clinical trials . The manufacturer has indicated plans to submit a regulatory application in the first quarter of 2027 . Early access programs have been announced for a limited number of patients meeting specific medical criteria .
I hope this overview is helpful for your research. Would you like me to explain how tricell compares to other metabolic research compounds?
